$91.58−2.41 (−2.56%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
Mirum Pharmaceuticals (MIRM) Institutional Ownership
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
Sources Ownership filingsQuarter ended How we compute thisNot investment advice
5 figures withheld by our checks. Each blank figure names its reason.
13F fund flowQuarter ended Jun 30, 2026*. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 140 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 331 filers, Jun 30, 2026
# 13F FUNDS
331
13F VALUE
$8.3B
71.2M shares
Not reported in the company's filings for this period.
Insider trades · latest filings (Form 4)routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Acquired · Option exercise | 20,000 | $2.94 | ↗ |
| Nov 4, 2026 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Disposed · Open-market sale | 20,000 | $90.00 | ↗ |
| Nov 4, 2026 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Disposed · Option exercise | 20,000Employee Stock Option (right to buy) | — | ↗ |
| Oct 16, 2026 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Acquired · Option exercise | 16,112 | $19.24 | ↗ |
| Oct 16, 2026 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Disposed · Option exercise | 16,112Employee Stock Option (right to buy) | — | ↗ |
| Oct 9, 2026 | Myers Robert Paul | Chief Medical Officer | Acquired · Grant / award | 40,000Employee Stock Option (right to buy) | — | ↗ |
| Oct 9, 2026 | Myers Robert Paul | Chief Medical Officer | Acquired · Grant / award | 25,000Restricted Stock Units | — | ↗ |
| Oct 6, 2026 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Acquired · Option exercise | 5,305 | $19.19 | ↗ |
| Oct 6, 2026 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Acquired · Option exercise | 6,892 | $15.87 | ↗ |
| Oct 6, 2026 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Disposed · Option exercise | 5,305Employee Stock Option (right to buy) | — | ↗ |
| Oct 6, 2026 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Disposed · Option exercise | 6,892Employee Stock Option (right to buy) | — | ↗ |
| Sep 14, 2026 | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | Disposed · Open-market sale | 9,943 | $98.37 | ↗ |
| Sep 11, 2026 | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | Acquired · Option exercise | 18,333 | — | ↗ |
| Sep 11, 2026 | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | Disposed · Option exercise | 18,333Restricted Stock Units | — | ↗ |
| Sep 2, 2026 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Disposed · Open-market sale | 658 | $100.00 | ↗ |
| Sep 1, 2026 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Acquired · Option exercise | 30,000 | $2.94 | ↗ |
| Sep 1, 2026 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Disposed · Open-market sale | 8,312 | $98.08 | ↗ |
| Sep 1, 2026 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Disposed · Open-market sale | 21,688 | $98.91 | ↗ |
| Sep 1, 2026 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Disposed · Option exercise | 30,000Employee Stock Option (right to buy) | — | ↗ |
| Aug 18, 2026 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Acquired · Option exercise | 40,000 | $6.27 | ↗ |
* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How many 13F filers hold Mirum Pharmaceuticals?
Mirum Pharmaceuticals was held by 331 13F filers as of Jun 30, 2026.
Not investment advice.

